methylguanidine has been researched along with Ventricular Dysfunction, Left in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, KH; Chen, TH; Wang, JJ | 1 |
1 other study(ies) available for methylguanidine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Preischemic treatment with melatonin attenuates liver reperfusion-induced impairment of cardiac function.
Topics: Animals; Antioxidants; Biomarkers; Cardiac Catheterization; Creatine Kinase, MB Form; Disease Models, Animal; Liver; Liver Diseases; Male; Melatonin; Methylguanidine; Myocardial Contraction; Myocardium; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke Volume; Time Factors; Troponin I; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |